ADVANCE JR
Natural health product licensed in Canada
- Licence holder
- Future Formulations Inc.
- NPN or DIN-HM
- 02242350
- Status
- Active licence
- Licence date
- 16 October 2009
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 75 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 50.1 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacine Source : Niacine | 4.17 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 33.4 mg | 200,400 µg |
| Calcium Source : Citrate de calcium | 33.4 mg | 200,400 µg |
| Cuivre Source : Citrate de cuivre | 0.085 mg | 510 µg |
| Chrome Source : Produit de chélation de chrome et de PVH | 12.5 mcg | 75 µg |
| Acide pantothénique Source : D-Pantothénate de calcium | 4.17 mg | 25,020 µg |
| Folate Source : Acide folique | 0.035 mg | Not calculated |
| Bêta-carotène Source : Bêta-carotène tout trans Potency : 93.75 mcg Vitamin A | 187.5 mcg EAR | Not calculated |
| Bêta-carotène Source : Bêta-carotène tout trans Potency : 1,250 UI | Not specified | Not calculated |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 8.35 mcg | 50.1 µg |
| Choline Source : Bitartrate de choline | 4.17 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Lactobacillus, Glutathione, Protéase, Cellulase, Rutine, Rice bran, Maltase, Stéarate de magnésium, Invertase, Bioflavonoïdes
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Daily multi vitamin mineral supplement - a factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02242350
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.